[Osteoporosis. New aspects of physiopathology and therapy].
D000328:Adult; D000367:Age Factors; D000375:Aging; D001846:Bone Development; D001842:Bone and Bones / Q000032:analysis / Q000503:physiopathology; D002116:Calcitonin / Q000627:therapeutic use; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D050723:Fractures, Bone / Q000150:complications; D006406:Hematoma / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders; D009132:Muscles / Q000503:physiopathology; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy*; D059408:Pain Management; D010710:Phosphates / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D012737:Sex Factors
D010710:Phosphates; D002116:Calcitonin; D005459:Fluorides
Osteoporose. Neue Aspekte der Pathophysiologie und der Therapie.